Last Updated: August 9, 2026

Patent: 10,413,607

✉ Email this page to a colleague

Summary for Patent: 10,413,607

Title:	Antibody specifically binding to ErbB3 and use thereof
Abstract:	An antibody that specifically binds to ErbB3 or an antigen-binding fragment thereof, and use thereof, are provided. The antibody that specifically binds to ErbB3 or an antigen-binding fragment thereof may be effectively used to prevent or treat a disease related to activation or overexpression of ErbB3 protein.
Inventor(s):	Bae; Dong Goo (Gyeonggi-do, KR), Kim; Mi Young (Seoul, KR), Hur; Young Mi (Gyeonggi-do, KR), Hong; Mi Rim (Seoul, KR)
Assignee:	ISU ABXIS CO., LTD. (Gyeonggi-Do, KR)
Application Number:	15/563,227
Patent Claims:	see list of patent claims

Details for Patent 10,413,607

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	September 25, 1998	10,413,607	2036-11-02
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	February 10, 2017	10,413,607	2036-11-02
Eli Lilly And Company	ERBITUX	cetuximab	Injection	125084	February 12, 2004	10,413,607	2036-11-02
Eli Lilly And Company	ERBITUX	cetuximab	Injection	125084	March 28, 2007	10,413,607	2036-11-02
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,413,607

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2017099362	⤷ Start Trial
United States of America	2018085455	⤷ Start Trial
Taiwan	I615406	⤷ Start Trial
Taiwan	201726742	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.